You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, Nov. 2, 2020 /PRNewswire/ -- The "Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global clinical microbiology market size is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.5%. Factors such as the technological advancements in the market are propelling the growth of the clinical microbiology market. Additionally, rising inclination epidemics like COVID-19 and investments from private and public sectors affect the growth of the clinical microbiology market. However, unfavorable reimbursement scenarios in some countries are hampering the growth of this market. The recent COVID-19 global pandemic has also impacted the clinical microbiology market. Demand from the main end-users has declined as key regions, and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens. The reagent segment to witness the highest growth rate in the clinical microbiology market, by product, during the forecast period. The reagent segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), the increasing trend of reagent rental agreements along with instrument sales, and a rising number of life science researches in the field of specific reagents for targeted infectious disease diagnosis and treatment, especially across emerging countries. The respiratory diseases accounted for the largest share of the clinical microbiology market, by diseases, in 2019. The respiratory diseases segment accounted for the largest share of the clinical microbiology market in 2019. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (such as TB, asthma, COPD, and bronchitis) across developing countries, and growth in the number of epidemic outbreaks of respiratory infections. The hospitals & diagnostics centers segment accounted for the largest share of the clinical microbiology, by end-users, in 2019. The hospitals and diagnostic centers segment accounted for the largest market share in 2019. The large share of this segment is attributed to the high incidence of target diseases (such as tuberculosis, HIV-AIDS, malaria, and epidemic diseases), availability of technologically advanced products (such as molecular diagnostic products and PCR and NGS-based instruments) for infectious disease diagnosis, growing awareness among doctors and clinicians regarding the advantages offered by molecular diagnostic products for fast and effective disease diagnosis, and ongoing expansion of healthcare infrastructure across emerging countries. The Asia Pacific market to grow at the highest CAGR during the forecast period. The clinical microbiology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related to genome-based infectious disease diagnosis, supportive regulations for the development and commercialization of advanced clinical microbiology products, rising healthcare expenditure, an increasing number of hospitals and clinical diagnostic laboratories in India and China, expanding research base across India, China, and Japan, and the increasing incidence of infectious diseases are the major factors driving the growth of the APAC clinical microbiology market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Clinical Microbiology Market Overview4.2 Clinical Microbiology Market, by Product, 2020 Vs. 2025 (USD Million)4.3 Asia-Pacific: Clinical Microbiology Market, by End-user and Country (2019)4.4 Geographic Analysis: Clinical Microbiology Market, by Disease (2019)4.5 Clinical Microbiology Market: Geographic Growth Opportunities5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Technological Advancements in Disease Diagnostics5.2.1.2 Rising Incidence of Infectious Diseases and Growing Outbreaks of Epidemics5.2.1.3 Increased Funding and Public-Private Investments5.2.2 Restraints5.2.2.1 Limited Reimbursement Policies for Microbiology Testing Procedures5.2.3 Opportunities5.2.3.1 Improving Healthcare Infrastructure Across Emerging Countries5.2.4 Challenges5.2.4.1 Operational Barriers Related to the Use of Diagnostic Tests5.2.4.2 Bundled Sales of Microbiology Testing Products - a Key Challenge for Small and Emerging Reagent Manufacturers5.3 Impact of the COVID-19 Pandemic on the Clinical Microbiology Market5.4 Regulatory Scenario5.5 Ecosystem Coverage5.6 Technology Analysis5.7 Pricing Analysis6 Microbiology Testing Market, by Application6.1 Introduction6.2 Pharmaceutical6.2.1 Growing Volume of Pharmaceutical Drugs Manufactured is the Major Factor Driving Market Growth6.3 Food Testing6.3.1 Food Testing is the Fastest-Growing Application Segment of the Market6.4 Clinical6.4.1 Growing Procedural Volume of Clinical Diagnostic Tests Will Propel Market Growth6.5 Energy6.5.1 Increasing Consumption & Production of Biofuel to Drive Market Growth6.6 Chemical & Material Manufacturing6.6.1 Chemical & Material Manufacturing Applications to Witness Steady Growth During the Forecast Period6.7 Environmental6.7.1 Rising Incidence of Air- & Water-Borne Diseases to Support Market Growth7 Clinical Microbiology Market, by Product7.1 Introduction7.2 Instruments7.2.1 Laboratory Instruments7.2.1.1 Incubators7.2.1.1.1 Incubators Will Continue to Dominate the Clinical Microbiology Instruments Market7.2.1.2 Gram Stainers7.2.1.2.1 Gram Stainers are Among the Most Widely Used Clinical Microbiology Instruments7.2.1.3 Bacterial Colony Counters7.2.1.3.1 Bacterial Colony Counters are Used During Diagnostic Procedures7.2.1.4 Autoclave Sterilizers7.2.1.4.1 Autoclave Sterilizers are Used to Eliminate the Risk of Microbial Contamination7.2.1.5 Microbial Air Samplers7.2.1.5.1 Microbial Air Samplers are Significant Instruments Used in Diagnosing Airborne Diseases7.2.1.6 Blood Culture Systems7.2.1.6.1 Blood Culture Systems are Used for End-To-End Blood Sample Processing7.2.1.7 Anaerobic Culture Systems7.2.1.7.1 Anaerobic Culture Systems Help to Maintain an Anaerobic Environment7.2.1.8 Microbial Culture Systems7.2.1.8.1 Microbial Culture Systems are Automated Systems for the Culturing of Samples7.2.1.9 Petri Dish Fillers7.2.1.9.1 Petri Dish Fillers are Designed to Work Reliably in the Absence of the Operator7.2.1.10 Other Laboratory Instruments7.2.2 Microbiology Analyzers7.2.2.1 Molecular Diagnostic Instruments7.2.2.1.1 Molecular Diagnostic Instruments to Register the Highest Growth in the Forecast Period7.2.2.2 Microscopes7.2.2.2.1 Microscopes are Particularly Helpful During the Preliminary Identification of Pathogens7.2.2.3 Mass Spectrometers7.2.2.3.1 High Accuracy of Mass Spectrometers to Drive Their Adoption7.3 Reagents7.3.1 Pathogen-Specific Kits7.3.1.1 Pathogen-Specific Kits Provide Efficient Mechanical Disruption of Difficult-To-Lyse Microbes7.3.2 General Reagents7.3.2.1 General Reagents Offer Significant Data Reproducibility8 Clinical Microbiology Market, by Disease8.1 Introduction8.2 Respiratory Diseases8.2.1 Respiratory Diseases Segment to Register the Highest Growth Rate During the Forecast Period8.3 Bloodstream Infections8.3.1 Bloodstream Infections Can Lead to a Reduced Risk of Antibiotic Resistance8.4 Gastrointestinal Diseases8.4.1 Gastrointestinal Diseases Have a Higher Prevalence in Developing Countries8.5 Sexually Transmitted Diseases8.5.1 Rising Prevalence of STDs Across Major Markets to Propel the Adoption of Clinical Microbiology Products8.6 Urinary Tract Infections8.6.1 Growing Number of UTI Cases Will Drive Market Growth8.7 Periodontal Diseases8.7.1 Expanding Product Pipelines of Market Players to Support Market Growth8.8 Other Diseases9 Clinical Microbiology Market, by End-user9.1 Introduction9.2 Hospitals & Diagnostic Centers9.2.1 Hospitals & Diagnostic Centers are the Largest End-users of Clinical Microbiology Products9.3 Custom Lab Service Providers9.3.1 Custom Lab Service Providers are the Fastest-Growing End-users of the Clinical Microbiology Market9.4 Academic & Research Institutes9.4.1 High Prevalence of Infectious Diseases to Support Market Growth10 Clinical Microbiology Market, by Region10.1 Introduction10.2 North America10.3 Europe10.4 Asia-Pacific10.5 Latin America10.6 the Middle East & Africa11 Competitive Landscape11.1 Overview11.2 Market Share Analysis11.3 Competitive Scenario11.3.1 Key Product Launches & Approvals11.3.2 Key Partnerships & Collaborations11.3.3 Key Acquisitions11.3.4 Key Expansions12 Company Evaluation Matrix and Company Profiles12.1 Company Evaluation Matrix Definition and Methodology12.1.1 Vendor Inclusion Criteria12.1.2 Stars12.1.3 Emerging Leaders12.1.4 Pervasive12.1.5 Participants12.2 Company Profiles12.2.1 3M12.2.2 Abbott Laboratories12.2.3 Agilent Technologies12.2.4 Becton, Dickinson and Company12.2.5 Biomerieux12.2.6 Bio-Rad Laboratories12.2.7 Bruker Corporation12.2.8 Danaher Corporation12.2.9 Hologic, Inc.12.2.10 Merck KGaA12.2.11 Neogen Corporation12.2.12 Qiagen12.2.13 Roche Diagnostics12.2.14 Shimadzu Corporation12.2.15 Thermo Fisher Scientific12.2.16 Emerging Players12.2.16.1 Biotechnology Solutions12.2.16.2 Hardy Diagnostics12.2.16.3 Liofilchem12.2.16.4 Rapid Micro Biosystems12.2.16.5 TCS Biosciences13 Appendix For more information about this report visit https://www.researchandmarkets.com/r/g4281y Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Worldwide Clinical Microbiology Industry to 2025 - Featuring 3M, Abbott Laboratories & Agilent Technologies Among Others